ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.54
Dividend & Yield0.02£ (0.76%)
Beta 0.64
Market capitalization 580.56M
Operating cash flow 29.9M
ESG Scores unknown

Company description

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.

Sector: Healthcare - Industry: Medical Instruments & Supplies

Financial data

Financial Statements

Cashflow Statement 2019-01-01 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 1.69M -1.27M -2.29M 2.1M
Total Cashflows From Investing Activities -4.3M -29.57M -26.77M -6.33M
Net Borrowings -858k -925k -1.81M -1.28M
Total Cash From Financing Activities -3.5M -3.58M -5.82M -5.11M
Change To Operating Activities
Issuance Of Stock 1.03M 1.67M 604k 1.09M
Net Income 22.49M 18.92M 8.58M 17.48M
Change In Cash 13.94M -11.64M -10.92M 19.14M
Effect Of Exchange Rate 71k -187k 162k -458k
Total Cash From Operating Activities 21.67M 21.7M 21.51M 31.02M
Depreciation 3.26M 4.84M 5.74M 7.07M
Change To Account Receivables -6.81M -574k 10.26M -1.77M
Other Cashflows From Financing Activities -581k -709k -735k -700k
Change To Netincome 3.84M 1.24M 17k 3.42M
Capital Expenditures -3.06M -2.67M -2.35M -1.77M

Income Statement 2019-01-01 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax 28.27M 24.26M 10.09M 21.98M
Net Income 22.49M 18.92M 8.58M 17.48M
Selling General Administrative 34.63M 35.56M 34.73M 38.45M
Gross Profit 63.41M 60.48M 46.04M 61.07M
Ebit 28.88M 25.3M 11.56M 23M
Operating Income 28.88M 25.3M 11.56M 23M
Interest Expense -581k -737k -694k -672k
Income Tax Expense 5.78M 5.34M 1.5M 4.5M
Total Revenue 102.6M 102.37M 86.8M 108.6M
Cost Of Revenue 39.19M 41.88M 40.76M 47.53M
Total Other Income ExpenseNet -605k -1.04M -1.48M -1.01M
Net Income From Continuing Ops 22.49M 18.92M 8.58M 17.48M
Net Income Applicable To Common Shares 22.49M 18.92M 8.58M 17.48M

Balance Sheet Statement 2019-01-01 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 32.49M 35.75M 36.34M 36.83M
Total Stockholder Equity 172.72M 191.24M 202.21M 212.68M
Other Current Liabilities 8.25M 5.25M 2.46M 4.57M
Total Assets 205.22M 226.98M 238.56M 249.51M
Common Stock 10.67M 10.74M 10.77M 10.8M
Other Current Assets 715k 1.32M
Retained Earnings 116.56M 132.47M 137.72M 151.35M
Treasury Stock 8.77M 10.26M 15.9M 11.99M
Cash 76.39M 64.75M 53.83M 72.97M
Total Current Liabilities 19.48M 17.18M 14.71M 17.01M
Other Stockholder Equity 8.92M 10.42M 16.07M 12.16M
Property, Plant, and Equipment 27.85M 27.71M 30.06M 27.44M
Total Current Assets 119.18M 111.76M 97.17M 114.97M
Net Tangible Assets 118.36M 109.38M 98.63M 116.16M
Net Receivables 26.17M 27.02M 19.5M 20.89M
Accounts Payable 3.96M 7.4M 6.79M 4.88M


Insider Transactions

Here are the insider transactions of stock shares related to ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Meredith (Andrew Christopher)D2022-05-10453.38k
Meredith (Andrew Christopher)D2022-05-1028.73k
Meredith (Andrew Christopher)Sold at price 3.35 per share.D2022-05-10246.38k
Johnson (Eddie)D2022-05-108.95k
Invesco Asset Management LtdD2022-04-29
GroupamaD2022-04-29
Hargreave Hale LtdD2022-04-29
Octopus Investments LtdD2022-04-29
Rathbone Investment Management LtdD2022-04-29
Rensburg Sheppards Investment Management LimitedD2022-04-29
Charles Stanley Group PLCD2022-04-29
Meredith (Andrew Christopher)Sold at price 3.78 per share.D2022-03-187.2k
Meredith (Andrew Christopher)Bought at price 3.78 per share.D2022-03-187.2k
Meredith (Andrew Christopher)Sold at price 3.78 per share.D2022-03-185.8k
Meredith (Andrew Christopher)Bought at price 3.78 per share.D2022-03-185.8k
Meredith (Andrew Christopher)D2021-12-31
Charles Stanley Group PLCD2021-12-31
Allen (Peter Vance)D2021-12-31
Invesco Asset Management LtdD2021-12-31
Johnson (Eddie)D2021-12-31
Octopus Investments LtdD2021-12-31
Rathbone Investment Management LtdD2021-12-31
Rensburg Sheppards Investment Management LimitedD2021-12-31
Freer (Penny A)D2021-12-31
GroupamaD2021-12-31
Hargreave Hale LtdD2021-12-31
Octopus Investments LtdD2021-10-081.52M
Kames Capital PLCD2021-07-28670.18k
Johnson (Eddie)Bought at price 3.85 per share.D2021-05-119.61k
Meredith (Andrew Christopher)Bought at price 3.85 per share.D2021-05-1113.86k
Meredith (Andrew Christopher)D2021-04-0923.37k
Meredith (Andrew Christopher)D2021-04-093.01k
Meredith (Andrew Christopher)Sold at price 3.30 per share.D2021-04-0928.16k
Johnson (Eddie)D2021-04-0917.25k
Johnson (Eddie)Sold at price 3.30 per share.D2021-04-0919.19k
Kames Capital PLCD2021-03-31
Charles Stanley Group PLCD2021-03-31
Octopus Investments LtdD2021-03-31
Rensburg Sheppards Investment Management LimitedD2021-03-31
GroupamaD2021-03-31
Hargreave Hale LtdD2021-03-31
Meredith (Andrew Christopher)Sold at price 3.25 per share.D2021-03-2533.39k
Meredith (Andrew Christopher)Bought at price 3.25 per share.D2021-03-2533.39k
GroupamaD2021-02-26
Hargreave Hale LtdD2021-02-26
Kames Capital PLCD2021-02-26
Octopus Investments LtdD2021-02-26
Rensburg Sheppards Investment Management LimitedD2021-02-26
Charles Stanley Group PLCD2021-02-26
Hargreave Hale LtdD2021-01-2065.83k
Octopus Investments LtdD2021-01-071.02M

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

Here is the result of two systematic investment strategies applied to ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

The following chart shows the equity curve of the two systematic investment strategies applied to ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P:

ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 22.12% on the backtest period.

Performance at glance

Performance

22.12 %

Latent gain

484.0 £

Invested capital

2188.0 £

Annualized return

5.37 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

This is the result of two momentum investment strategies applied to ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

The following chart shows all the entries opened by the momentum investment system on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P:

ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P momentum entries
  • The first momentum investment strategy would give 29.98% of return on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P. That represents 1001.5£ of latent gain with 3340.5£ of employed capital.
  • The second momentum investment strategy would give 32.72% of return on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P. That represents 1070.5£ of latent gain with 3271.5£ of employed capital.
Performance at glance (1Q Momentum)

Performance

29.98 %

Latent gain

1001.5 £

Invested capital

3340.5 £

Annualized return

34.89 %
Performance at glance (2Q Momentum)

Performance

32.72 %

Latent gain

1070.5 £

Invested capital

3271.5 £

Annualized return

8.99 %

Momentum equity curve on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

The following chart shows the equity curve of the two momentum strategies applied to ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P:

ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P momentum equity

Note: the dividends potentially given by ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

The following chart shows the employed capital evolution of the two momentum strategies on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P since the beginning:

ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

Buy the dip entry openings on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

The performance achieved by the robo-advisor on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P is 73.96%. That represents 142.0$ of latent gain with 192.0£ of employed capital. The following chart shows ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

73.96 %

Latent gain

142.0 £

Invested capital

192.0 £

Annualized return

34.89 %

Equity curve of the strategy applied to ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

The following chart shows the result of the investment strategy applied to ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P:

ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

Note: the dividends potentially given by ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

The following chart shows the employed capital evolution since the beginning of the investment strategy on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P:

ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

In this section, I will compare the three previous investment strategies applied to ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P.

Equity curve comparison on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P investment strategy comparison

Employed capital comparison on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P investment comparison

Performance comparison on ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 22.12% 484.0£ 2188.0£ 5.37%
Momentum 1 quarter 29.98% 1001.5£ 3340.5£ 7.73%
Momentum 2 quarters 32.72% 1070.5£ 3271.5£ 8.99%
Non-directional 73.96% 142.0£ 192.0£ 34.89%
Annualized return comparison

Automatic investment

5.37 %

Momentum 1Q

8.99 %

Momentum 2Q

8.99 %

Non-directional

34.89 %

Correlated stocks

Here are the most positively and negatively correlated stocks with ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P and the other stocks. There may be false positives or some missing correlated stocks. If the price of ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P
Country United Kingdom
City Winsford
Address Premier Park
Phone 44 1606 863 500
Website www.admedsol.com
FullTime employees 700
Industry Medical Instruments & Supplies
Sector Healthcare
Exchange XLON
Ticker AMS.XLON
Market www.londonstockexchange.com

ADVANCED MEDICAL SOLUTIONS GROUP PLC ORD 5P ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown